Target Ovarian Cancer works closely with GPs to support them in diagnosing women early, and in giving the best support to the women they work with. Find information on guidelines, training tools and resources to support you and your patients with ovarian cancer.
The UK has amongst the lowest survival rates in Europe for ovarian cancer, with a five year survival rate of just 43 per cent. If diagnosed at the earliest stages, up to 90 per cent of women would survive five years or more. Sadly, three quarters of women are diagnosed with ovarian cancer once it has already spread. The role of GPs in diagnosing ovarian cancer early is crucial, but diagnosis is not always easy.
How we support GPs
Evidence now shows that most women are symptomatic, regardless of the stage at which they are diagnosed. Target Ovarian Cancer offers free online training and a range of resources to support you and your patients:
GPs must refer a woman for diagnostic tests at the first suspicion of ovarian cancer, in order to rule it out. Make sure you have the most up-to-date information and support available on everything to do with diagnosis.
Once a woman has been diagnosed with ovarian cancer, her main point of contact will be her consultant and nurses. Having the support of a GP through symptoms and post-treatment is crucial to a woman’s wellbeing and road to recovery.
Get trained up
Access our award-winning, free, online learning modules to improve, or refresh, your knowledge of the signs and symptoms of ovarian cancer, and earn CPD points.
Familial history information
Could one of your patients be at risk of ovarian cancer because of their family history? If one of your patients has been diagnosed with ovarian cancer could their family be at risk?
Find downloads and a range of useful resources for GPs, and for GPs to give to women with ovarian cancer.
GP Advisory Board
Find out more about Target Ovarian Cancer’s GP Advisory Board. With expertise from leading GPs around the UK, the Board will shape and advise our work in increasing early diagnosis and reducing risk.